K. Stenzel

CHEMICALLY-MODIFIED FIBER COLLAGEN HEMOSTATIC AGENTS
20170 citationsauthor #2
Three-dimensional culture of mouse renal carcinoma cells in agarose macrobeads selects for a subpopulation of cells with cancer stem cell or cancer progenitor properties.
201153 citationsauthor #17
Hydrophilic agarose macrobead cultures select for outgrowth of carcinoma cell populations that can restrict tumor growth.
201116 citationsauthor #21
Deceased-donor kidney transplantation: improvement in long-term survival.
201142 citationsauthor #19
Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis.
200910 citationsauthor #7
Neutralization of endotoxin by a phospholipid emulsion in healthy volunteers.
200549 citationsauthor #8
Trapped stem cells and uses thereof
20040 citationsauthor #4
Safety and Pharmacokinetics of an Endotoxin-Binding Phospholipid Emulsion
200316 citationsauthor #8
capable of compositions to rapid growth, restriktierten cells that produce proliferation-suppressing materials and their use
19990 citationsauthor #5
Compositions restricted cells able to grow rapidly producing materials suppressors of proliferation and uses thereof.
19990 citationsauthor #5
Compositions of-restricted cells, which is suitable for rapid growth and produces materials which suppresses proliferation, and uses thereof
19990 citationsauthor #2
Producing a diffusible biological product containing the cells, the implantable agarose kollageenihelmiä and their use
19980 citationsauthor #5
Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.
1998561 citationsauthor #6
Effect of nifedipine on renal allograft function and survival beyond one year.
19979 citationsauthor #9
The implantable agarose-collagen bead containing cells which form a diffusible biological product, and their use
19970 citationsauthor #5
Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure.
1997246 citationsauthor #4
Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.
19966 citationsauthor #9
Long-term preservation of islets of Langerhans in hydrophilic macrobeads.
199622 citationsauthor #7
Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression.
199561 citationsauthor #9
Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection.
199563 citationsauthor #10
Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth.
1994134 citationsauthor #3
Involvement of tumor necrosis factor in development of anti-CD3 monoclonal antibody induced pulmonary edema.
19940 citationsauthor #3
Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.
199418 citationsauthor #8
Long term results of subtotal parathyroidectomy in patients with end-stage renal disease.
199427 citationsauthor #7
Modulation of mouse mesangial cell proliferation by thiourea and lipoxygenase inhibitors.
19944 citationsauthor #2
How well is hypertension controlled in CAPD patients?
199433 citationsauthor #4
Transmembrane signaling requirements of T cells.
19930 citationsauthor #4
End-stage renal disease in systemic lupus erythematosus.
199366 citationsauthor #2
Two-signal model for T-cell activation: molecular mechanisms.
19932 citationsauthor #3
EXCELLENT OUTCOME WITH A CALCIUM CHANNEL BLOCKER—SUPPLEMENTED IMMUNOSUPPRESSIVE REGIMEN IN CADAVERIC RENAL TRANSPLANTATION: A POTENTIAL STRATEGY TO AVOID ANTIBODY INDUCTION PROTOCOLS
199332 citationsauthor #11
INHIBITION OF INTERLEUKIN 2 RECEPTOR EXPRESSION IN NORMAL HUMAN T CELLS BY CYCLOSPORINE: DEMONSTRATION AT THE mRNA, PROTEIN, AND FUNCTIONAL LEVELS1,2
199220 citationsauthor #5
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
199130 citationsauthor #8
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
19915 citationsauthor #7
Ferro-mitogens: iron-containing compounds with lymphocyte-stimulatory properties.
199121 citationsauthor #3
Adoptive Immunotherapy for Renal Adenocarcinoma: Use of Oxidizing Mitogen-Treated Mononuclear Leukocytes and Continuous Infusion of Interleukin-2
19900 citationsauthor #1
Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity.
199084 citationsauthor #3
Kidney transplantation in insulin dependent diabetic patients: improved survival and rehabilitation.
198913 citationsauthor #3
Immune stimulatory properties of metalloporphyrins.
198957 citationsauthor #3
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2.
198931 citationsauthor #8
Antitumor properties of mononuclear cells activated by combined treatment with oxidizing mitogens and interleukin-2: basic and clinical studies.
19891 citationsauthor #2
OKT3-associated adverse reactions: mechanistic basis and therapeutic options.
198912 citationsauthor #5
Analysis of spontaneous blastogenesis profiles in recipients of renal allografts.
19890 citationsauthor #4
URINARY CALCULI IN RENAL TRANSPLANT RECIPIENTS
198851 citationsauthor #5
Altered nucleic acid contents of mononuclear cells in blood of renal allograft recipients.
19881 citationsauthor #5
Activation of human T cells with the physiological regulator of protein kinase C.
198813 citationsauthor #4
HUMAN MEMORY T CELL ACTIVATION EFFECTS OF MONOCLONAL ANTIBODIES DIRECTED AT INTERLEUKIN‐2, RECEPTORS FOR INTERLEUKIN‐2, OR INTERFERON‐γ
19886 citationsauthor #2
Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2.
198812 citationsauthor #9
Human T Cell Activation: Participation of T Cell Differentiation Antigen Cluster 2 (CD2) in the Generation and/or Transduction of Accessory Cell Signals
19880 citationsauthor #7
IN VIVO EFFECTS OF HIGH‐DOSE STEROIDS ON NUCLEIC ACID CONTENT OF IMMUNOCOMPETENT CELLS OF RENAL ALLOGRAFT RECIPIENTS
19881 citationsauthor #5
Periodate and recombinant interleukin-2-activated autologous leukocytes can induce regression of metastases of renal cancer.
19881 citationsauthor #7
Cell cycle analysis of activated mononuclear blood cells of renal allograft recipients.
19870 citationsauthor #5
Biochemical and ultrastructural alterations accompany the anti-proliferative effect of butyrate on melanoma cells.
198730 citationsauthor #5
Osmotic enhancement of mitogenic stimulation in PNA-negative murine thymocytes.
19871 citationsauthor #4
Effect of immunosuppressants on OKT3 associated T cell activation: clinical implications.
198715 citationsauthor #3
The anti-proliferative effect of lithium chloride on melanoma cells and its reversion by myo-inositol.
198725 citationsauthor #6
Anti-melanoma properties of chemical inducers of differentiation: In vitro and in vivo studies
19870 citationsauthor #6
Anti-tumor properties of lymphocytes activated by the oxidizing mitogens.
19869 citationsauthor #8
Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide.
198644 citationsauthor #6
Hypertension in Kidney Disease
19865 citationsauthor #2
Early effects of TPA on protein kinase activity in murine thymocytes. Reduction of protein kinase C activity in the cytosol and increase of Ca2+ and phospholipid-independent kinase activity in the particulate fractions.
19865 citationsauthor #3
Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact.
198518 citationsauthor #5
Activation of murine thymocyte subpopulations by the oxidizing mitogens: evidence for a sialylated, mitogen-reactive site on both PNA-positive and PNA-negative cells.
19851 citationsauthor #4
Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center.
1985119 citationsauthor #10
Selective effects of TPA and IL-1 on protein phosphorylation in murine thymocytes.
198514 citationsauthor #2
Differential effects of tumor promoters on cAMP production: inhibition of receptor-mediated and potentiation of cholera toxin-mediated stimulation.
198522 citationsauthor #2
Proteinuria following Renal Transplantation
19851 citationsauthor #1
Inhibition of pokeweed mitogen-induced B cell differentiation by compounds containing primary amine or hydrazine groups.
19857 citationsauthor #6
Dimethylthiourea inhibition of melanoma cell growth in vitro and in vivo.
19859 citationsauthor #5
12-O-Tetradecanoylphorbol-13-acetate enhances glycolysis in rat thymocytes.
19850 citationsauthor #3
Impact of Renal Donation
198524 citationsauthor #10
Evolution of immunosuppressive treatment modalities for renal transplant recipients.
19840 citationsauthor #7
Mitogenic and comitogenic properties of the indole alkaloid class of tumor promoters
19844 citationsauthor #5
Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
198465 citationsauthor #5
Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
198425 citationsauthor #5
The Na+-ionophore monensin enhances glucose uptake in mouse thymocytes.
19841 citationsauthor #2
INDUCTION OF IMMUNE ALTERATIONS AND SUCCESSFUL RENAL TRANSPLANTATION WITH A SIMPLIFIED METHOD OF DONOR‐SPECIFIC BLOOD TRANSFUSION
198416 citationsauthor #10
A REAPPRAISAL OF THE EFFECTS OF MONOCLONAL ANTIBODIES DIRECTED AT T CELL DIFFERENTIATION ANTIGENS
19846 citationsauthor #4
Presumed assault or accommodative reactions involved in human renal transplantation.
19841 citationsauthor #6
Hydroxyl radical scavengers inhibit human natural killer cell activity
1984129 citationsauthor #6
Mitogenic properties of neuraminidase and galactose oxidase-treated lymphoblastoid cells and plasma membranes for peripheral blood lymphocytes.
198411 citationsauthor #4
Activation of T cells via cell-cell interaction: role of growth factors and accessory cells.
19840 citationsauthor #3
Perfusion of plasma over Staphylococcus aureus: release of bacterial products is related to regression of tumor.
19844 citationsauthor #6
Successful renal transplantation in a patient with primary hyperoxaluria.
198310 citationsauthor #3
Agents that increase cellular cAMP inhibit production of interleukin-2, but not its activity.
198337 citationsauthor #4
Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus.
198323 citationsauthor #6
Effect of polar organic compounds on leukemic cells: Butyrate‐induced partial remission of acute myelogenous leukemia in a child
1983173 citationsauthor #5
Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
198318 citationsauthor #3
12–0‐tetradecanoylphorbol‐13‐acetatea and concanavalin a enhance glucose uptake in thymocytes by different mechanisms
198313 citationsauthor #2
Prognostic patterns in acute renal failure: the New York Hospital, 1981-1982.
198321 citationsauthor #3
Decreased macrophage-mediated suppression of lymphocyte activation in chronic renal failure.
19839 citationsauthor #4
Inhibition of phorbol ester-mediated interleukin-2 production by cellular differentiating agents.
19839 citationsauthor #4
Systemic lupus erythematosus in patients with chronic renal failure.
198342 citationsauthor #2
The advantage of measurement of intact PTH in the prediction of clinical response and calcium metabolism after subtotal parathyroidectomy for renal osteodystrophy.
19832 citationsauthor #7
On the mechanisms of inhibition of lymphocyte mitogenesis by high conA concentrations.
19837 citationsauthor #4
Membrane Galactosyl Sites: Role in Lymphocyte Proliferation and Differentiation
19833 citationsauthor #2
Focal segmental glomerulosclerosis in renal transplants.
198353 citationsauthor #6
Plasmapheresis in a patient with angioimmunoblastic lymphadenopathy: Improvement in clinical and immunologic abnormalities
19839 citationsauthor #4
Maternal-fetal immunity: presence of specific cellular hyporesponsiveness and humoral suppressor activity in normal pregnancy and their absence in preeclampsia.
198313 citationsauthor #7
A new class of immunosuppressants: Agents that induce erythroid differentiation in Friend leukemia cells inhibit cellular and humoral immune responses
19830 citationsauthor #4
Lupus erythematosus-like disease due to hydrazine.
198354 citationsauthor #6

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT